Basal cell carcinomas of the face: Supported Surgery

K. Tourabi[1a*], M.A. Ennouhi[1b] , B. Abir[1c], T. Nassim-Sabah[1d], M. Lakouichmi[1e], M. Mliha touati[2]
Page No. 22-29

The basal cell carcinoma is by far the epithelial malignant tumor most widespread. The facial
involvement represents over 65% of cases and is a risk factor for recurrence. The aim of our work
is to recall the principles and methods of surgical treatment.On a nine-month period, we supported
fifteen patients with basal cell carcinomas of the facthe average age of our patients is 66ans (range
39-80ans). -sexe: there is a male predominance. Tumor -Size: it varies between 6 and 32mm (mean
= 16 mm).-Localisation: Nasal disease is the most common. -Marge Excision: calculated by
thepathologist, it varies between 3 and 15mm. Histological -type: 8cas in nodular infiltrating and 6.
The skin cover has appealed to: the controlled healing (1 case), direct suture (2 cases); the total
skin graft (4cas); and loco -régionaux shreds (9 cases).Early surgical recovery is deplored (skin
graft removal and flap coverage).The aesthetic results are satisfactory; otherwise we can not
comment on the reliability of oncological results seen insufficient decline that is available (9-18
months).Surgical treatment of basal cell carcinoma is the only guarantor of healing; gold oncologic
and aesthetic requirements, particularly in terms of the face, sometimes make this difficult
treatment. Improving outcomes through prevention, early detection of lesions, the close
collaboration of pathologists and the creation of consultative committees bringing together multi -
disciplinaire: Dermatologists and Plastic -chirurgiens oncologists for the management of difficult
cases.
Keywords : Epithélioma- Basocellulaire- Chirurgie- pathological anatomy.